Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2013

Feb 4, 2013

30016_dirs_2013-02-04_62ea7b4f-e12d-41cd-b53d-6261f026674f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-01-31

Reporting Person: NAQUI ALI (Corporate Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-01-31 Common Stock M 11498 $41.935 Acquired 23418 Direct
2013-01-31 Common Stock S 8540 $95.53 Disposed 14878 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-01-31 Non-Qualified Stock Option (right to buy) $41.935 M 8540 Disposed 2014-02-13 Common Stock (8540) Direct
2013-01-31 Incentive Stock Option (right to buy) $41.935 M 2958 Disposed 2014-02-13 Common Stock (2958) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 2,300 shares on 02/14/2008, 02/14/2009 and 02/14/2010 and the remaining 1,640 shares on 02/14/2011.

F2: Grant of options to buy shares of common stock becomes exercisable as to 660 shares on 02/14/2011 and the remaining 2,298 shares on 02/14/2012.